Clinical trial
New Biomarkers in Acute and Chronic Inflammatory Demyelinating Polyradiculoneuropathies
NCT04249752 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Biomarkers in Acute and Chronic Inflammatory Demyelinating Polyradiculoneuropathies
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2020
- Completion date
- January 30, 2025
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cidp, guillain-barre syndrome